REGISTERED
on 02 Apr 2024
Last Applicant/ Owned by
351 Paseo Nuevo, Floor 2
Santa Barbara
CA
93101
Serial Number
97777914 filed on 02th Feb 2023
Registration Number
7349127 registered on 02th Apr 2024
Correspondent Address
Jeffery M. Lillywhite
Filing Basis
1. filed as use application
2. use application currently
Disclaimer
NO DATA
CANCERVAX
Pharmaceutical drug development services; Pharmaceutical research services; Providing information about medical research in the field of cancer, pharmaceutical drugs, cancer risks, and Immunotherapy Color is not claimed as a feature of the mark. The mark consists of stylized text CANCERVAX.
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Pharmaceutical drug development services; Pharmaceutical research services; Providing information about medical research in the field of cancer, pharmaceutical drugs, cancer risks, and Immunotherapy
First Use Date in General
27th Sep 2022
First Use Date in Commerce
27th Sep 2022
Mark Details
Serial Number
No 97777914
Mark Type
No Service Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Description of Design Search
The mark consists of stylized text CANCERVAX.
Legal History
| Status Date | Action Taken |
|---|---|
| 02th Apr 2024 | REGISTERED-SUPPLEMENTAL REGISTER |
| 02th Apr 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 26th Feb 2024 | APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER |
| 07th Feb 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 06th Feb 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 06th Feb 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 13th Nov 2023 | NON-FINAL ACTION WRITTEN |
| 13th Nov 2023 | NON-FINAL ACTION E-MAILED |
| 13th Nov 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 31st Oct 2023 | ASSIGNED TO EXAMINER |